Axe Compute INC. (AGPU) — 8-K Filings
All 8-K filings from Axe Compute INC.. Browse 41 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (41)
- 8-K Filing — Apr 22, 2026
-
Axe Compute Inc. Files 8-K: Officer Changes & More
— Apr 1, 2026 Risk: medium
Axe Compute Inc. filed an 8-K on April 1, 2026, reporting changes in officers and compensatory arrangements. The filing also includes other events and financial -
Axe Compute Inc. Reports Board and Executive Changes
— Dec 12, 2025 Risk: medium
Axe Compute Inc. announced on December 10, 2025, a change in its board of directors and executive compensation arrangements. The filing details the departure of -
Predictive Oncology Files 8-K with Corporate Updates
— Dec 11, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on December 11, 2025, reporting events as of December 9, 2025. The filing indicates amendments to its Articles of Incorpor -
Predictive Oncology Files 8-K with Financials
— Dec 2, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on December 2, 2025, reporting on events as of December 1, 2025. The filing includes financial statements and exhibits, wi - 8-K Filing — Nov 25, 2025
-
Predictive Oncology Inc. Files 8-K
— Nov 20, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on November 20, 2025, reporting "Other Events." The filing indicates the company was formerly known as Skyline Medical Inc - 8-K Filing — Nov 17, 2025
-
Predictive Oncology Files 8-K
— Oct 29, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on October 29, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Skyl -
Predictive Oncology Files 8-K on Shareholder Nominations
— Oct 16, 2025 Risk: medium
Predictive Oncology Inc. filed an 8-K on October 16, 2025, reporting shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing indicates that the -
Predictive Oncology Files 8-K
— Oct 8, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on October 8, 2025, reporting on events that occurred on October 7, 2025. The filing indicates a Regulation FD Disclosure -
Predictive Oncology Inc. Files 8-K with Material Agreements & Officer Changes
— Sep 30, 2025 Risk: medium
Predictive Oncology Inc. announced on September 25, 2025, the entry into a material definitive agreement. The company also disclosed unregistered sales of equit -
Predictive Oncology Files 8-K
— Sep 29, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on September 29, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerl -
Predictive Oncology Files 8-K on Security Holder Matters
— Sep 25, 2025 Risk: medium
Predictive Oncology Inc. filed an 8-K on September 25, 2025, reporting events that occurred on September 19, 2025. The filing indicates material modifications t -
Predictive Oncology Files 8-K: Director & Officer Changes
— Sep 12, 2025 Risk: medium
Predictive Oncology Inc. filed an 8-K on September 12, 2025, reporting events on September 9, 2025. The filing indicates changes related to the departure and el -
Predictive Oncology Files 8-K on Material Agreement & Equity Sales
— Sep 2, 2025 Risk: medium
Predictive Oncology Inc. entered into a material definitive agreement on August 26, 2025. The company also reported on unregistered sales of equity securities. -
Predictive Oncology Files 8-K on Financials
— Aug 14, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on August 14, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Ex -
Predictive Oncology Acquires Bio-Genetics, Raises $1.5M
— Jul 24, 2025 Risk: medium
Predictive Oncology Inc. announced on July 23, 2025, that it has entered into a definitive agreement to acquire all outstanding shares of privately held Bio-Gen -
Predictive Oncology Inc. Files 8-K
— Jul 18, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on July 18, 2025, reporting on events and financial statements as of December 31, 2024. The company, formerly known as Sky -
Predictive Oncology Faces Delisting Concerns
— Jul 11, 2025 Risk: high
Predictive Oncology Inc. filed an 8-K on July 11, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The specific -
Predictive Oncology Files 8-K: Material Agreement & Equity Sales
— Jul 8, 2025 Risk: medium
Predictive Oncology Inc. entered into a material definitive agreement on July 1, 2025. The company also reported on unregistered sales of equity securities and -
Predictive Oncology Faces Delisting Concerns
— Jun 11, 2025 Risk: high
Predictive Oncology Inc. filed an 8-K on June 11, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing a -
Predictive Oncology Files 8-K
— Jun 6, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on June 6, 2025, reporting an event that occurred on June 2, 2025. The filing is categorized under 'Other Events' and incl -
Predictive Oncology Files 8-K on Financials
— May 15, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition. The filing includes financial statements -
Predictive Oncology Files 8-K
— Apr 7, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on April 7, 2025, reporting an event that occurred on April 3, 2025. The filing is categorized under Regulation FD Disclos -
Predictive Oncology Files 8-K on Financials
— Apr 1, 2025 Risk: low
Predictive Oncology Inc. filed an 8-K on April 1, 2025, reporting on its results of operations and financial condition. The filing includes financial statements -
Predictive Oncology Inc. Files 8-K for Material Agreement
— Mar 20, 2025 Risk: medium
Predictive Oncology Inc. filed an 8-K on March 20, 2025, reporting a material definitive agreement entered into on March 14, 2025. The filing also includes othe -
Predictive Oncology Inc. Files 8-K for Material Agreement
— Mar 5, 2025 Risk: medium
Predictive Oncology Inc. entered into a Material Definitive Agreement on February 28, 2025. The filing also includes financial statements and exhibits related t -
Predictive Oncology Inc. Files 8-K for Material Agreement
— Feb 19, 2025 Risk: medium
Predictive Oncology Inc. announced on February 18, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales o -
Predictive Oncology Files 8-K with Material Agreement
— Jan 6, 2025 Risk: medium
Predictive Oncology Inc. filed an 8-K on January 6, 2025, reporting a material definitive agreement. The filing also includes financial statements and exhibits. -
Predictive Oncology Faces Delisting Concerns
— Nov 22, 2024 Risk: high
Predictive Oncology Inc. filed an 8-K on November 22, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company, formerl -
Predictive Oncology Files 8-K on Financials
— Nov 13, 2024 Risk: low
Predictive Oncology Inc. filed an 8-K on November 13, 2024, reporting on its results of operations and financial condition. The filing includes financial statem -
Predictive Oncology Faces Nasdaq Delisting Warning
— Sep 20, 2024 Risk: high
Predictive Oncology Inc. received a notice on September 19, 2024, indicating it failed to meet a continued listing rule or standard for the Nasdaq Capital Marke -
Predictive Oncology Files 8-K on Financials
— Aug 14, 2024 Risk: low
Predictive Oncology Inc. filed an 8-K on August 14, 2024, reporting on its results of operations and financial condition. The filing includes financial statemen -
Predictive Oncology Inc. Files 8-K: Material Agreement & Equity Sales
— Jul 29, 2024 Risk: medium
Predictive Oncology Inc. announced on July 25, 2024, that it entered into a material definitive agreement. The company also reported on unregistered sales of eq -
Predictive Oncology Files 8-K
— May 30, 2024 Risk: low
Predictive Oncology Inc. filed an 8-K on May 30, 2024, reporting an event that occurred on May 28, 2024. The filing is categorized under 'Other Events' and 'Fin -
Predictive Oncology Inc. Files 8-K on Financials
— May 15, 2024 Risk: low
Predictive Oncology Inc. filed an 8-K on May 15, 2024, reporting on its financial condition and results of operations. The filing details the company's business -
Predictive Oncology Enters Material Definitive Agreement
— May 6, 2024 Risk: medium
Predictive Oncology Inc. announced on May 3, 2024, that it entered into a material definitive agreement. The company, formerly known as Skyline Medical Inc., is -
Predictive Oncology to Acquire Bio-Genetics for $1.5M + Stock
— Apr 8, 2024 Risk: medium
Predictive Oncology Inc. announced on April 3, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of privately held Bio-Gen -
Predictive Oncology 8-K: Leadership & Compensation Changes Reported
— Feb 8, 2024 Risk: medium
Predictive Oncology Inc. reported on February 2, 2024, that it filed an 8-K regarding the departure or election of directors and officers, as well as compensato -
Predictive Oncology Files 8-K on Shareholder Vote Submission
— Jan 4, 2024
Predictive Oncology Inc. filed an 8-K on January 4, 2024, reporting on matters submitted to a vote of security holders on December 28, 2023. This filing, under
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX